Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has submitted a certificate to the exchange as required under SEBI's Depositories and Participants Regulations, 2018. This is a routine regulatory compliance filing, typically related to the company's Registrar and Share Transfer Agent or depository operations. No financial figures, business updates, or strategic changes are mentioned. The filing appears to be administrative in nature and part of the company's ongoing listing obligations.
This is a routine compliance disclosure with no material impact on shareholders or the stock price. Investors can disregard it as standard regulatory housekeeping.